Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Han, Su Xia ^a   Wang, Jun Lan ^a   Guo, Xi Jing ^a   He, Chen Chen ^a   Ying, Xia ^a   Ma, Jin Lu ^a   Zhang, Yuan Yuan ^a   Zhao, Qian ^a   Zhu, Qing ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SAL LIKE PROTEIN 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; SALL4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MALE; MICROSCOPY; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR INVASION; AGED; BLOOD; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS B, CHRONIC; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; SURVIVAL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84900312646     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/262385     Document Type: Article

References (30)

1. Shen Q. J., Fan J., Yang X. R., Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. The Lancet Oncology 2012 13 8 817 826
2. Marquardt J. U., Snorri S., Thorgeirsson. Sall4 in "stemness"- driven hepatocarcinogenesis. The New England Journal of Medicine 2013 368 2316 2318
3. Leake I., Importance of oncofetal gene, SALL4, in a subset of hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2013 10 8 441
4. Forghanifard M. M., Moghbeli M., Role of SALL4 in the progression and metastasis of colorectal cancer. Journal of Biomedical Science 2013 20, article 6 10.1186/1423-0127-20-6
5. Ushiku T., Shinozaki A., Shibahara J., Iwasaki Y., Tateishi Y., Funata N., Fukayama M., SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. American Journal of Surgical Pathology 2010 34 4 533 540 2-s2.0-77950196211 10.1097/PAS.0b013e3181d1dcdd
6. Oikawa T., Kamiya A., Zeniya M., Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology 2013 57 4 1469 1483
7. Deisch J., Raisanen J., Rakheja D., Immunoexpression of SALL4 in Wilms tumors and developing kidney. Pathology and Oncology Research 2011 17 3 639 644 2-s2.0-80052760824 10.1007/s12253-011-9364-0
8. Itou J., Matsumoto Y., Yoshikawa K., Toi M., Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer. FEBS Letters 2013 587 18 3115 3121 10.1016/j.febslet.2013.07.049
9. Cao D., Humphrey P. A., Allan R. W., SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 2009 115 12 2640 2651 2-s2.0-67649220203 10.1002/cncr.24308
10. Mei K., Liu A., Allan R. W., Wang P., Lane Z., Abel T. W., Wei L., Cheng H., Guo S., Peng Y., Rakheja D., Wang M., Ma J., Rodriguez M. M., Li J., Cao D., Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Modern Pathology 2009 22 12 1628 1636 2-s2.0-71149088322 10.1038/modpathol.2009.148
11. Wang F., Liu A., Peng Y., Rakheja D., Wei L., Xue D., Allan R. W., Molberg K. H., Li J., Cao D., Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. American Journal of Surgical Pathology 2009 33 10 1529 1539 2-s2.0-70349684394 10.1097/PAS.0b013e3181ad25d5
12. Cao D., Li J., Guo C. C., Allan R. W., Humphrey P. A., SALL4 is a novel diagnostic marker for testicular germ cell tumors. American Journal of Surgical Pathology 2009 33 7 1065 1077 2-s2.0-67649562737 10.1097/PAS.0b013e3181a13eef
13. Cao D., Guo S., Allan R. W., Molberg K. H., Peng Y., SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. American Journal of Surgical Pathology 2009 33 6 894 904 2-s2.0-67549105495 10.1097/PAS.0b013e318198177d
14. Jones B., Liver cancer: SALL4-a cancer market and target. Nature Reviews Clinical Oncology 2013 10 8 426 10.1038/nrclinonc.2013.112
15. Yong K. J., Gao C., Lim J. S., Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. The New England Journal of Medicine 2013 368 2266 2276
16. Yang J., Chai L., Gao C., Fowles T. C., Alipio Z., Dang H., Xu D., Fink L. M., Ward D. C., Ma Y., SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood 2008 112 3 805 813 2-s2.0-50949096867 10.1182/blood-2007-11-126326
17. Shuai X., Zhou D., Shen T., Wu Y., Zhang J., Wang X., Li Q., Overexpression of the novel oncogene SALL4 and activation of the Wnt/ β -catenin pathway in myelodysplastic syndromes. Cancer Genetics and Cytogenetics 2009 194 2 119 124 2-s2.0-70349210687 10.1016/j.cancergencyto.2009.06.006
18. Ma Y., Cui W., Yang J., Qu J., Di C., Amin H. M., Lai R., Ritz J., Krause D. S., Chai L., SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood 2006 108 8 2726 2735 2-s2.0-33749185394 10.1182/blood-2006-02-001594
19. Cui W., Kong N. R., Ma Y., Amin H. M., Lai R., Chai L., Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia. Modern Pathology 2006 19 12 1585 1592 2-s2.0-33751215123 10.1038/modpathol.3800694 (Pubitemid 44789927)
20. Kobayashi D., Kuribayshi K., Tanaka M., Watanabe N., SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer. International Journal of Oncology 2011 38 4 933 939 2-s2.0-79952338489 10.3892/ijo.2011.929
21. Cao D., Guo S., Allan R. W., Molberg K. H., Peng Y., SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. American Journal of Surgical Pathology 2009 33 6 894 904 2-s2.0-67549105495 10.1097/PAS.0b013e318198177d
22. Fujimoto M., Sumiyoshi S., Yoshizawa A., SALL4 immunohistochemistry in nonsmall cell lung carcinomas. Histopathology 2014 64 2 309 311 10.1111/his.12241
23. Cao D., Li J., Guo C. C., Allan R. W., Humphrey P. A., SALL4 is a novel diagnostic marker for testicular germ cell tumors. American Journal of Surgical Pathology 2009 33 7 1065 1077 2-s2.0-67649562737 10.1097/PAS.0b013e3181a13eef
24. Lee J.-S., Heo J., Libbrecht L., Chu I.-S., Kaposi-Novak P., Calvisi D. F., Mikaelyan A., Roberts L. R., Demetris A. J., Sun Z., Nevens F., Roskams T., Thorgeirsson S. S., A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nature Medicine 2006 12 4 410 416 2-s2.0-33645742425 10.1038/nm1377
25. Li A., Jiao Y., Yong K. J., SALL4 is a new target in endometrial cancer. Oncogene 2013 10.1038/onc.2013.529
26. Ushiku T., Shinozaki A., Shibahara J., Iwasaki Y., Tateishi Y., Funata N., Fukayama M., SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. American Journal of Surgical Pathology 2010 34 4 533 540 2-s2.0-77950196211 10.1097/PAS.0b013e3181d1dcdd
27. Jain D., Sal-like protein 4: an epithelial and germ cell marker. Human Pathology 2013 44 7 1453 10.1016/j.humpath. 2013.03.015
28. Zhang L., Xu Z., Xu X., SALL4, a novel marker for human gastric carcinogenesis and metastasis. Oncogen 2013 10.1038/onc.2013.495
29. Ueno S., Lu J., He J., Aberrant expression of SALL4 in acute B-cell lymphoblastic leukemia: mechanism, function and implication for a potential novel therapeutic target. Experimental Hematology 2014 10.1016/j.exphem.2014.01. 005
30. Zeng S. S., Yamashita T., Kondo M., The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. Journal of Hepatology 2014 60 1 127 134 10.1016/j.jhep.2013.08.024